Avid Bioservices Inc (CDMO)

[drumstick57]

This came up on the Yahoo board but I think posters here have already torn it apart??...??? but this is what is going around.


Chimera Research:More PPHM downside 26-Aug-12 01:26 pm
I don't find their reasoning valid though.

www.chimeraresearchgroup.com/2012...

Any comments from longs?

Re: Chimera Research:More PPHM downside 20 minutes ago
I do find it interesting that there was no mention of bavi-HCV.

I personally don't buy the stat-sig argument against bavi-NSCLC, I think the Phase II should show enough compelling data to get a partner to fund a stat sig Phase III. I certainly never bought the PP arguemnt that they were going after accelerated approval. That never made sense to me.

I also thought this was an interesting statement "We’re also kind of surprised that no principal investigators in the trial aren’t making a push to get the placebo arm patients on Bavituximab" I did not know that could be an option for patients on the control arm but I am not an expert. In any case, it would be great to hear from clinicians themselves about how bavi performed.